Daniel J. Becker, Director at Day One Biopharmaceuticals, Inc. (DAWN), bought 5,000 shares at $16.00 ($80K) on 2021-06-01, disclosed to the SEC on 2021-06-01.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| PAND | BUY | 2020-11-23 | $6.0M | — | Filing → |
| PAND | BUY | 2020-11-19 | $867K | — | Filing → |
| PAND | BUY | 2020-07-21 | $13.0M | — | Filing → |